Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 1/2012

01-01-2012 | Original Paper

Improved survival among patients with base of tongue and tonsil cancer in the United States

Authors: Guo-Pei Yu, Vikas Mehta, Daniel Branovan, Qiang Huang, Mia Hashibe, Zuo-Feng Zhang, Stimson P. Schantz

Published in: Cancer Causes & Control | Issue 1/2012

Login to get access

Abstract

Objective

To examine if survival has changed over the last 20 years in patients with base of tongue and tonsil cancers in the United States.

Methods

Using SEER data, we employed Kaplan–Meier method to draw survival curves and calculate survival rates, and estimated adjusted hazard ratios (HR).

Results

From the 1980s to the 2000s, the 5-year overall survival rates statistically significantly improved by 100% from 25 to 51% among patients with one primary base of tongue cancer and 28–60% among those with one primary tonsil cancer (p values for trend <0.001). In addition, the 5-year cancer-specific survival improved by 222.4 and 276%, respectively, among two types of patients. Survival improvement was more pronounced among male patients than among female patients regardless of young or old age, while the improvement was generally consistent among patients with different tumor stages and treatment methods. In contrast, however, those patients with subsequent multiple cancers showed no improvement in overall survival over time.

Conclusions

The survival of patients with base of tongue and tonsil cancer has significantly improved over the last decades in the United States. Whether the improvement is associated with HPV infection, screening, or early detection is worthy to study in future.
Literature
1.
Ryerson AB, Peters ES, Coughlin SS et al (2008) Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998–2003. Cancer 113:2901–2909PubMedCrossRef
2.
Schantz SP, Yu GP (2002) Head and neck cancer incidence trends in young Americans, 1973–1997, with a special analysis for tongue cancer. Arch Otolaryngol Head Neck Surg 128:268–274PubMed
3.
Shiboski CH, Schmidt BL, Jordan RC (2005) Tongue and tonsil carcinoma: increasing trends in the US population ages 20–44 years. Cancer 103:1843–1849PubMedCrossRef
4.
Frisch M, Hjalgrim H, Jaeger AB, Biggar RJ (2000) Changing patterns of tonsillar squamous cell carcinoma in the United States. Cancer Causes Control 11:489–495PubMedCrossRef
5.
Kingsley K, O’Malley S, Ditmyer M, Chino M (2008) Analysis of oral cancer epidemiology in the US reveals state-specific trends: implications for oral cancer prevention. BMC Public Health 8:87PubMedCrossRef
6.
Mellin H, Friesland S, Lewensohn R, Dalianis T, Munck-Wikland E (2000) Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer 89:300–304PubMedCrossRef
7.
Kreimer AR, Clifford GM, Boyle P, Franceschi S (2005) Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomark Prev 14:467–475PubMedCrossRef
8.
Attner P, Du J, Nasman A et al (2010) The role of human papillomavirus in the increased incidence of base of tongue cancer. Int J Cancer 126:2879–2884PubMed
9.
Dunne EF, Unger ER, Sternberg M et al (2007) Prevalence of HPV infection among females in the United States. JAMA 297:813–819PubMedCrossRef
10.
Dahlgren L, Dahlstrand HM, Lindquist D et al (2004) Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients. Int J Cancer 112:1015–1019PubMedCrossRef
11.
af Geijersstam V, Wang Z, Lewensohn-Fuchs I et al (1998) Trends in seroprevalence of human papillomavirus type 16 among pregnant women in Stockholm, Sweden, during 1969–1989. Int J Cancer 76:341–344PubMedCrossRef
12.
Zhen W, Karnell LH, Hoffman HT et al (2004) The National Cancer Data Base report on squamous cell carcinoma of the base of tongue. Head Neck 26:660–674PubMedCrossRef
13.
Brunin F, Mosseri V, Jaulerry C et al (1999) Cancer of the base of the tongue: past and future. Head Neck 21:751–759PubMedCrossRef
14.
Ritchie JM, Smith EM, Summersgill KF et al (2003) Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer 104:336–344PubMedCrossRef
15.
Schwartz SR, Yueh B, McDougall JK, Daling JR, Schwartz SM (2001) Human papillomavirus infection and survival in oral squamous cell cancer: a population-based study. Otolaryngol Head Neck Surg 125:1–9PubMedCrossRef
16.
Ang KK, Harris J, Wheeler R et al (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363:24–35PubMedCrossRef
17.
Fakhry C, Westra WH, Li S et al (2008) Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100:261–269PubMedCrossRef
18.
Lam L, Logan RM, Luke C (2006) Epidemiological analysis of tongue cancer in South Australia for the 24-year period, 1977–2001. Aust Dent J 51:16–22PubMedCrossRef
19.
Chaturvedi AK, Engels EA, Anderson WF, Gillison ML (2008) Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 26:612–619PubMedCrossRef
20.
Surveillance, Epidemiology, and End Results (SEER) Program (www.​seer.​cancer.​gov) SEER*Stat Database: incidence—SEER 17 Regs limited-use + Hurricane Katrina Impacted Louisiana Cases, Nov 2008 Sub (1973–2006 varying), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2009, based on the November 2008 submission
21.
Spiegelman D, Hertzmark E (2005) Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol 162:199–200PubMedCrossRef
22.
Shiboski CH, Shiboski SC, Silverman S Jr (2000) Trends in oral cancer rates in the United States, 1973–1996. Community Dent Oral Epidemiol 28:249–256PubMedCrossRef
23.
Cosetti M, Yu GP, Schantz SP (2008) Five-year survival rates and time trends of laryngeal cancer in the US population. Arch Otolaryngol Head Neck Surg 134:370–379PubMedCrossRef
24.
Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP (2005) Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 114:806–816PubMedCrossRef
25.
Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W et al (eds) (2010) SEER cancer statistics review, 1975–2007, National Cancer Institute. Bethesda, MD, http://​seer.​cancer.​gov/​csr/​1975_​2007/​, based on November 2009 SEER data submission, posted to the SEER web site, 2010
26.
US Department of Health and Human Services (1994) Preventing tobacco use among young people: a report of the surgeon general. US Dept of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking on Health, Atlanta
27.
Centers for Disease Control and Prevention (CDC) (2002) Cigarette smoking among adults—United States, 2000. MMWR Morb Mortal Wkly Rep 51:642–645
28.
Kujan O, Glenny AM, Duxbury J, Thakker N, Sloan P (2005) Evaluation of screening strategies for improving oral cancer mortality: a Cochrane systematic review. J Dent Educ 69:255–265PubMed
29.
Cruz GD, Ostroff JS, Kumar JV, and Gajendra S (2005) Preventing and detecting oral cancer. Oral health care providers’ readiness to provide health behavior counseling and oral cancer examinations. J Am Dent Assoc 136:594–601. (quiz 681–682)
30.
Netuveli G, Sheiham A, Watt RG (2006) Does the ‘inverse screening law’ apply to oral cancer screening and regular dental check-ups? J Med Screen 13:47–50PubMedCrossRef
31.
Pinto LH, Canary PC, Araujo CM, Bacelar SC, Souhami L (1991) Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 21:557–562PubMedCrossRef
32.
Horiot JC, Le Fur R, N’Guyen T et al (1992) Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 25:231–241PubMedCrossRef
33.
Harrison LB, Lee HJ, Pfister DG et al (1998) Long term results of primary radiotherapy with/without neck dissection for squamous cell cancer of the base of tongue. Head Neck 20:668–673PubMedCrossRef
34.
Mendenhall WM, Stringer SP, Amdur RJ et al (2000) Is radiation therapy a preferred alternative to surgery for squamous cell carcinoma of the base of tongue? J Clin Oncol 18:35–42PubMed
35.
Bourhis J, Le Maitre A, Baujat B, Audry H, Pignon JP (2007) Individual patients’ data meta-analyses in head and neck cancer. Curr Opin Oncol 19:188–194PubMedCrossRef
36.
Pignon JP, Bourhis J, Domenge C, Designe L (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 355:949–955PubMed
37.
Pignon JP, le Maitre A, Bourhis J (2007) Meta-Analyses of Chemotherapy in Head and Neck Cancer (MACH-NC): an update. Int J Radiat Oncol Biol Phys 69:S112–S114PubMedCrossRef
38.
Budach W, Hehr T, Budach V, Belka C, Dietz K (2006) A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck. BMC Cancer 6:28PubMedCrossRef
Metadata
Title
Improved survival among patients with base of tongue and tonsil cancer in the United States
Authors
Guo-Pei Yu
Vikas Mehta
Daniel Branovan
Qiang Huang
Mia Hashibe
Zuo-Feng Zhang
Stimson P. Schantz
Publication date
01-01-2012
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 1/2012
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-011-9864-y

Other articles of this Issue 1/2012

Cancer Causes & Control 1/2012 Go to the issue

Original paper

Dual effect of short interval between first and second birth on ductal breast cancer risk in Finland

Review article

Why mammography screening has not lived up to expectations from the randomised trials

Original paper

Reproductive factors and lymphoid neoplasms in Europe: findings from the EpiLymph case–control study

Original paper

Mammography capacity and appointment wait times: barriers to breast cancer screening

Original paper

Occupational risks and lung cancer burden for Chinese men: a population-based case–referent study

Original paper

Cholecystectomy and risk of pancreatic cancer: a meta-analysis of observational studies
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits